Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:59 AM
Ignite Modification Date:
2025-12-25 @ 1:59 AM
NCT ID:
NCT02935894
Eligibility Criteria:
Inclusion Criteria:
* 20-40 y
* Male
* Weight \> 110 pounds
Exclusion Criteria:
* Diagnosed active chronic diseases for which the individual is currently taking daily medication, including but not limited to:
* Diabetes mellitus
* Cardiovascular disease
* Cancer
* Gastrointestinal disorders
* Kidney disease
* Liver disease
* Bleeding disorders
* Asthma
* Autoimmune disorders
* Hypertension
* Osteoporosis
* Recent minor surgery (within 4 wk) or major surgery (within 16 wk)
* Recent antibiotic therapy (within 4 wk)
* Recent hospitalization (within 4 wk)
* Use of over-the-counter or prescription medications at the time of the study that directly affect endpoints of interest (e.g. hyperlipidemia, glycemic control, steroids, statins, anti-inflammatory agents, and weight loss aids)
* Adults who are not able to consent
* Under current medical supervision
* Ibuprofen intolerance or allergy
* Those with a bleeding disorder
* Current enrollee in a clinical research study.
* Individuals with blood clotting or platelet defect disorders
* Individuals with orthopedic limitations or cardiovascular risk that preclude participation in the physiological stimulation of sweat by light exercise portion of the study
* Individuals who are trained athletes or that regularly perform physical activity defined as "vigorous" by the Centers for Disease Control and Prevention
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
20 Years
Maximum Age:
40 Years
Study:
NCT02935894
Study Brief:
Protocol Section:
NCT02935894